article thumbnail

How pharma knowledge and marketing influences prescriptions written by doctors

eMediWrite

Knowledge marketing is a crucial method for influencing doctors’ prescription practises in the pharmaceutical business. E-detailing, or physical LBLs in which a medical representative uses an online platform, or print input respectively to detail a pharmaceutical product to a doctor.

Doctors 40
article thumbnail

AbbVie sucks

World of DTC Marketing

market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money. Sales of Humira earned AbbVie $20.7

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s position in the global pharmaceutical packaging and labelling market The authors highlighted that Europe led the worldwide market at 27 percent in 2022. The authors wrote that driving factors include increasing demand for branded drugs, over the counter medicines as well as specialty medicine.

article thumbnail

KFA-115 by Novartis for Melanoma: Likelihood of Approval

Pharmaceutical Technology

Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products.

article thumbnail

Understanding the Role of a Medical Representative: A Balanced View

Contrarian Sales Techniques

The Allure and Reality of Medical Sales When we think of a medical representative (often referred to as a "med rep"), images of well-dressed professionals with sleek briefcases, brimming with the latest pharmaceutical products, often come to mind. They seem to have an air of confidence, backed by the promise of modern medicine.

Medical 52
article thumbnail

KFA-115 by Novartis for Malignant Mesothelioma: Likelihood of Approval

Pharmaceutical Technology

Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products.

article thumbnail

Iptacopan hydrochloride by Novartis for Paroxysmal Nocturnal Hemoglobinuria: Likelihood of Approval

Pharmaceutical Technology

Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It was also under development for the treatment of idiopathic/primary membranous nephropathy.